TransMedics to report Q2 2026 financial results on August 4
TransMedics Group, Inc. will announce its Q2 2026 financial results on August 4, 2026, followed by a conference call at 4:30 p.m. ET. Investors can join via phone or webcast. The company focuses on organ transplant technologies.
*this image is generated using AI for illustrative purposes only.
TransMedics Group, Inc. announced it will release financial results for the second quarter of 2026 after market close on Tuesday, August 4, 2026. The company, a medical technology firm focused on organ transplant therapy, will host a conference call to discuss the performance.
The management team will conduct the call beginning at 4:30 p.m. ET / 1:30 p.m. PT. Investors can access the live event by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers, using access code 6054544.
A live and archived webcast of the conference call will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/ .
Key Event Details
| Event | Date | Time (ET) | Access Details |
|---|---|---|---|
| Q2 2026 Results Release | August 4, 2026 | After market close | N/A |
| Conference Call | August 4, 2026 | 4:30 p.m. | Domestic: (800) 715-9871 International: (646) 307-1963 Access Code: 6054544 |
TransMedics specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company develops technologies to preserve organ quality and increase utilization for treating end-stage heart, lung, and liver failure.
What key performance indicators will investors focus on during the Q2 2026 earnings call?
How might TransMedics' financial results impact its stock price and market sentiment?
What strategic initiatives or partnerships could TransMedics announce alongside its earnings?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
